Pfizer's Q3 Earnings Beat, Paxlovid Drives Sales Guidance Increase
PFE beats third-quarter estimates for earnings and sales. It raises 2024 earnings and revenue expectations.
| Ticker |
Sentiment |
Impact |
|
AZN
|
Neutral
|
8 %
|
|
PFE
|
Somewhat Bullish
|
40 %
|
|
BNTX
|
Neutral
|
8 %
|
